Ligand Pharma (LGND) Files $30M Mixed Shelf

Ligand Pharmaceuticals Inc. (Nasdaq: LGND), filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $30 million of Debt Securities, Preferred Stock, Common Stock, Debt Warrants, Equity Warrants, or any combination thereof.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Singularity Future Technology closes $5M registered direct offering
• ESS Tech closes $3.2M stock offering at $0.50 per share
• Global Interactive Technologies receives Nasdaq non-compliance notice